Progressing Prostate Carcinoma

Progressing Prostate Carcinoma Michael J. Haut, Joseph F. Harryhill, Jeffrey Rosenstock, Michael J. Warhol, Richard Vitti Oncologist 2001; 6: 183-196 Author Information and Disclosures Target Audience: Physicians who wish to advance their current knowledge of clinical cancer medicine in genitourinary cancer and are involved in providing patient care in a cancer care environment. Method of Physician Participation: Read course materials, complete course quiz and evaluation form (optional). Learning Objectives After completing this course, the reader should be able to: Understand the prognostic criteria, which determined selection of initial therapy of prostate carcinoma. Understand the role of radiation therapy salvage for relapsing disease. Know the available chemotherapeutic options for treating patients whose disease has become resistant to hormonal therapy. The NIH/FAES designates this educational activity for a maximum of 1 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

CME Activity Information Accreditation CME Instructions For Credit Privacy Statement Hardware/Software Requirements Release Date: July 24, 2002 Most Recent Review: July 24, 2003* Most Recent Update: July 24, 2002 Date Credit Expires: Apr. 10, 2007 Time to Complete: 1 hour Medium: Internet Online *Click here to learn more about our review process.